InvestorsHub Logo
Followers 6
Posts 2176
Boards Moderated 1
Alias Born 01/15/2019

Re: Drugdoctor post# 18225

Thursday, 10/06/2022 11:17:39 AM

Thursday, October 06, 2022 11:17:39 AM

Post# of 21240
I am sure their earnings will temporarily excite their base...as it usually does...because those shareholders arent too bright. Tilray is a flip stock. It runs better than any US company when there is US political news. As for the company, their stock went down over the last quarter...and significantly over the last year...so they should have derivative liabilities to help offset losses. Absurd that Simon made $19.5M in total compensation, for FY2022...up $6M from 2021...and the top 5 executives (including Simon) totaled $30.5M in compensation. Simon's base pay is set to go up $120K next year...and I believe he is supposed to receive a $10M bonus in December. However, their earnings will be terrible again, as the compensation report stated, "Fiscal Year 2022, the Compensation Committee determined Mr. Simon’s annual cash bonus to be $0." So obviously he has yet to hit whatever goals or benchmarks set to trigger this event.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SHWZ News